Q3 2026

A multidisciplinary pulmonary rehabilitation pathway for hospitalized patients with chronic lung disease and post-COVID syndrome: a prospective controlled cohort study

Aibo Zheng · Kai Sun · Shengjun Ma · Yan Jin · Wenjun Li · Zhiyu Chen · Feizhong Gong · Juan Pen · Xin Ming · Aibo Zheng
10.1186/s43168-026-00587-3 388 المشاهدات 0 الاقتباسات
0
الاقتباسات
388
المشاهدات
الملخص

Abstract

Background
Patients with chronic lung disease (CLD) and post-COVID syndrome suffer from multidimensional impairment that is often incompletely addressed by pharmacotherapy alone. We evaluated a ward-based multidisciplinary pathway integrating pharmacotherapy, psychological support, and pulmonary rehabilitation.


Methods

In this prospective controlled cohort study, 360 hospitalized patients with CLD and post-COVID syndrome received integrated multidisciplinary care (
n
 = 120) or usual care (
n
 = 240). The primary outcomes were changes in PaCO₂, FEV₁% predicted, and CT-assessed residual radiological abnormality extent. Patient-reported outcomes, functional capacity, inflammation, and 6-month follow-up data were also assessed. Analyses used adjusted regression and IPTW.



Results

Integrated care was associated with greater improvements in the three primary outcomes: PaCO₂, adjusted β − 0.98 mmHg (95% CI − 1.21 to − 0.75;
P
 < 0.001); FEV₁% predicted, adjusted β 2.35% points (95% CI 1.53 to 3.17;
P
 < 0.001); and CT-assessed residual abnormality extent, adjusted β − 0.55% points (95% CI − 0.87 to − 0.24;
P
 < 0.001). Integrated care was also associated with greater improvements in SGRQ score, SAS score, 15-minute walking distance, CRP, ESR, and sleep-quality score. The composite early clinical benefit rate was higher in the integrated-care group than in the usual-care group, with an adjusted OR of 1.91 (95% CI 1.21 to 3.01;
P
 = 0.006). At 6 months, sleep quality was better and symptom-related medication use was lower, while rehospitalisation, acute exacerbation, and CT progression rates were similar between groups.



Conclusions
The integrated pathway was associated with broader short-term clinical improvement and lower symptom-related treatment burden at follow-up, although rehospitalisation, acute exacerbation, and CT progression rates were similar between groups.

الاستشهاد بهذا المقال (APA)
Aibo, Z., Kai, S., Shengjun, M., Yan, J., Wenjun, L., Zhiyu, C., Feizhong, G., Juan, P., Xin, M., Aibo, Z. (2026). A multidisciplinary pulmonary rehabilitation pathway for hospitalized patients with chronic lung disease and post-COVID syndrome: a prospective controlled cohort study. Egyptian Journal of Bronchology. https://doi.org/10.1186/s43168-026-00587-3
أبحاث ذات صلة
Criteria and potential predictors of severity in patients with COVID-19
Niveen E. Zayed; Ahmad Abbas; Samah Mohamad Lutfy · 2022
24
استشهاد
393
Serum interleukin-6 in chronic obstructive pulmonary disease patients and its relation to severity a…
Fatma G. M. Hussein; Randa S. Mohammed; Rasha A. Khattab; Laila A. Al-Sharawy · 2022
24
استشهاد
391
Predictors of severity and mortality in COVID-19 patients
Hebatallah Hany Assal; Hoda M. Abdel-hamid; Sally Magdy; Maged Salah; Asmaa Ali; · 2022
19
استشهاد
391
Protective mechanism of quercetin and its derivatives in viral-induced respiratory illnesses
Wahyu Choirur Rizky; Muhammad Candragupta Jihwaprani; Mazhar Mushtaq · 2022
10
استشهاد
393
9
استشهاد
390
الوصول
عرض النص الكامل عبر DOI
نُشر في
الرقم الدولي ISSN 1687-8426
الربعية Q3
درجة المؤشر القياس العربي 82
التخصص Medicine & Health Sciences
الناشر Springer (Biomed Central Ltd.)
الدولة 🇪🇬 Egypt
عرض ملف المجلة →
المؤلفون
تفاصيل النشر
السنة 2026
اللغة English
أُضيف في 14 Aug 2026